JP Morgan Chase
ISEE

JP Morgan Chase’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

JP Morgan Chase’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-403,077
Closed -$15.9M – 7884
2023
Q2 		$15.9M Sell
403,077
-379,019
-48% -$13.4M ﹤0.01% 1873
2023
Q1 		$19M Buy
782,096
+83,003
+12% +$1.82M ﹤0.01% 1704
2022
Q4 		$15M Sell
699,093
-110,940
-14% -$2.37M ﹤0.01% 1889
2022
Q3 		$14.5M Sell
810,033
-113,564
-12% -$1.49M ﹤0.01% 1839
2022
Q2 		$8.88M Buy
923,597
+381,732
+70% +$4.79M ﹤0.01% 2267
2022
Q1 		$9.12M Buy
541,865
+460,137
+563% +$6.8M ﹤0.01% 2465
2021
Q4 		$1.37M Buy
81,728
+35,459
+77% +$581K ﹤0.01% 4156
2021
Q3 		$751K Buy
46,269
+7,139
+18% +$77.7K ﹤0.01% 4498
2021
Q2 		$246K Buy
39,130
+8,846
+29% +$57.1K ﹤0.01% 5130
2021
Q1 		$187K Sell
30,284
-5,445
-15% -$33.1K ﹤0.01% 5180
2020
Q4 		$247K Sell
35,729
-28,500
-44% -$182K ﹤0.01% 4730
2020
Q3 		$347K Sell
64,229
-45,738
-42% -$218K ﹤0.01% 4137
2020
Q2 		$561K Buy
109,967
+92,694
+537% +$386K ﹤0.01% 3807
2020
Q1 		$59K Buy
+17,273
New +$101K ﹤0.01% 4685
2019
Q4 		– Sell
-968
Closed -$1K – 5966
2019
Q3 		$1K Sell
968
-151,352
-99% -$176K ﹤0.01% 5670
2019
Q2 		$184K Buy
152,320
+149
+0.1% +$204 ﹤0.01% 4696
2019
Q1 		$215K Buy
152,171
+56,160
+58% +$78.5K ﹤0.01% 4605
2018
Q4 		$115K Buy
96,011
+94,234
+5,303% +$183K ﹤0.01% 4794
2018
Q3 		$4K Sell
1,777
-59,716
-97% -$149K ﹤0.01% 5580
2018
Q2 		$168K Buy
+61,493
New +$170K ﹤0.01% 4637
2018
Q1 		– Sell
-201,762
Closed -$629K – 5696
2017
Q4 		$629K Buy
201,762
+169,176
+519% +$476K ﹤0.01% 3969
2017
Q3 		$88K Sell
32,586
-8,842
-21% -$23.9K ﹤0.01% 4337
2017
Q2 		$106K Sell
41,428
-98,612
-70% -$269K ﹤0.01% 4158
2017
Q1 		$513K Buy
140,040
+24,986
+22% +$106K ﹤0.01% 3697
2016
Q4 		$556K Buy
115,054
+20,487
+22% +$608K ﹤0.01% 3713
2016
Q3 		$4.36M Buy
94,567
+1,986
+2% +$112K ﹤0.01% 2351
2016
Q2 		$4.72M Sell
92,581
-2,214
-2% -$110K ﹤0.01% 2332
2016
Q1 		$4.01M Sell
94,795
-1,735
-2% -$88.4K ﹤0.01% 2336
2015
Q4 		$7.58M Buy
96,530
+35,991
+59% +$2.08M ﹤0.01% 1978
2015
Q3 		$2.45M Buy
60,539
+1,450
+2% +$76.8K ﹤0.01% 2640
2015
Q2 		$3.08M Buy
59,089
+19,764
+50% +$983K ﹤0.01% 2665
2015
Q1 		$1.83M Buy
39,325
+26,891
+216% +$1.4M ﹤0.01% 2921
2014
Q4 		$558K Sell
12,434
-2,519
-17% -$106K ﹤0.01% 3619
2014
Q3 		$582K Sell
14,953
-466
-3% -$18.3K ﹤0.01% 3591
2014
Q2 		$652K Sell
15,419
-4,786
-24% -$176K ﹤0.01% 3027
2014
Q1 		$720K Sell
20,205
-63,091
-76% -$2.13M ﹤0.01% 2998
2013
Q4 		$2.7M Buy
+83,296
New +$2.47M ﹤0.01% 2564

JP Morgan Chase's ISEE Position: Q3 2023 in Review

JP Morgan Chase sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 403,077 shares — an estimated $15.9M sold.

JP Morgan Chase first reported a position in ISEE in Q4 2013 and held it in 37 quarters. The position peaked at $19M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • JP Morgan Chase reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • JP Morgan Chase sold 403,077 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $15.9M.
  • JP Morgan Chase first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 37 quarters.
  • JP Morgan Chase's IVERIC bio, Inc. Common Stock position peaked at $19M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.